The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck.

UYGUN K., Bilici A., KARAGÖL H., Caloglu M., ÇİÇİN İ., Aksu G., ...Daha Fazla

Cancer chemotherapy and pharmacology, cilt.64, sa.3, ss.601-5, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 64 Sayı: 3
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1007/s00280-008-0911-7
  • Dergi Adı: Cancer chemotherapy and pharmacology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.601-5
  • Anahtar Kelimeler: Inoperable head and neck cancer, Squamous cell, Weekly cisplatin, Three weekly, Cisplatin, Concurrent chemoradiotherapy, LOCALLY ADVANCED HEAD, RADIATION-THERAPY, RANDOMIZED-TRIAL, PHASE-II, CANCER, ONCOLOGY, EORTC
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Several studies have shown that the concurrent administration of chemotherapy (CHT) and radiotherapy (RT) is superior to RT alone in patients with inoperable non-metastatic squamous cell carcinoma of the head and neck (InSCCHN). We compared the efficacy and safety profile of RT and concurrent cisplatin CHT given in two different schedules to patients with previously untreated InSCCHN.